AXQ Capital LP Has $1.65 Million Stock Holdings in Encompass Health Corporation $EHC

Key Points

• AXQ Capital LP increased its Encompass Health stake by 416.2% in the fourth quarter, buying 12,493 additional shares and bringing its total holding to 15,495 shares worth about $1.65 million.
• Institutional ownership remains very high, with hedge funds and other institutions holding 97.25% of Encompass Health’s stock, and several other firms also reported major position increases.
• Analysts remain constructive on the stock overall: the consensus rating is “Buy” with an average price target of $142.75, even after Barclays trimmed its target to $140 and other firms issued bullish calls.

AXQ Capital LP boosted its position in Encompass Health Corporation (NYSE:EHC - Free Report) by 416.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 15,495 shares of the company's stock after buying an additional 12,493 shares during the quarter. AXQ Capital LP's holdings in Encompass Health were worth $1,645,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. AlphaCore Capital LLC bought a new position in Encompass Health in the fourth quarter valued at approximately $4,881,000. Tudor Investment Corp ET AL grew its stake in Encompass Health by 155.3% in the third quarter. Tudor Investment Corp ET AL now owns 210,712 shares of the company's stock valued at $26,765,000 after purchasing an additional 128,191 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Encompass Health by 5.3% in the third quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company's stock valued at $179,141,000 after purchasing an additional 70,387 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in Encompass Health by 3,059,159.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company's stock valued at $402,640,000 after purchasing an additional 3,793,358 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in Encompass Health by 1,070.9% in the fourth quarter. SG Americas Securities LLC now owns 88,054 shares of the company's stock valued at $9,346,000 after purchasing an additional 80,534 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Analyst Ratings Changes

EHC has been the subject of a number of analyst reports. Barclays decreased their price target on Encompass Health from $153.00 to $140.00 and set an "overweight" rating for the company in a research note on Tuesday, May 5th. Wall Street Zen upgraded Encompass Health from a "hold" rating to a "buy" rating in a research note on Saturday, May 2nd. TD Cowen began coverage on Encompass Health in a research note on Thursday. They set a "buy" rating and a $125.00 target price for the company. Finally, Leerink Partners set a $152.00 target price on Encompass Health in a research note on Friday, May 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, Encompass Health currently has a consensus rating of "Buy" and a consensus price target of $142.75.

Insider Activity

In other Encompass Health news, Treasurer Edmund Fay sold 11,937 shares of the firm's stock in a transaction on Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the transaction, the treasurer directly owned 89,325 shares of the company's stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Patrick William Tuer sold 682 shares of the business's stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares of the company's stock, valued at approximately $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.80% of the stock is owned by corporate insiders.

Encompass Health Stock Performance

Shares of NYSE EHC opened at $102.60 on Tuesday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17. The stock's fifty day moving average price is $103.40 and its two-hundred day moving average price is $105.28. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The firm has a market cap of $10.18 billion, a price-to-earnings ratio of 17.13, a P/E/G ratio of 2.31 and a beta of 0.72.

Encompass Health (NYSE:EHC - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating analysts' consensus estimates of $1.51 by $0.09. The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company's revenue for the quarter was up 9.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, equities analysts forecast that Encompass Health Corporation will post 5.96 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.19 per share. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health's dividend payout ratio is presently 12.69%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.